Bowen Acquisition Receives Nasdaq Delisting Notification for Non-Compliance

Bowen Acquisition (NASDAQ:BOWN) received a delisting determination letter from Nasdaq, citing non-compliance with Nasdaq Listing Rules. The company's securities are now subject to delisting from the exchange. Bowen Acquisition must appeal the decision within 45 days to avoid delisting.

New York, NY - Bowen Acquisition Corp (NASDAQ: BOWN), a special purpose acquisition company, received a delisting determination letter from Nasdaq on July 15, 2025, citing multiple compliance failures. The company's securities are now subject to delisting from the exchange. Bowen Acquisition has until July 22, 2025, to appeal the decision to a Nasdaq Hearings Panel to avoid delisting [1].

The delisting determination letter stated that Bowen Acquisition was not in compliance with several Nasdaq Listing Rules. These include maintaining a minimum market value of listed securities of $50 million for 30 consecutive trading days, having at least 1,100,000 publicly held shares, ensuring a market value of publicly held shares of at least $15 million for 30 consecutive trading days, and having at least 400 total shareholders [1].

Bowen Acquisition must appeal the decision within 45 days to avoid delisting. If the company requests a hearing, the suspension of trading will be temporarily halted for 15 days from the request date. The hearing panel will review the request for an extended stay and notify Bowen Acquisition of its conclusion as soon as practicable, but no later than 15 calendar days following the deadline to request the hearing [1].

Bowen Acquisition is currently working to complete its previously announced business combination with Shenzhen Qianzhi BioTechnology Co. Ltd. The company believes that this transaction will bring it back into compliance with the listing requirements. However, there is no guarantee that the combination will be completed or that compliance will be achieved [1].

The stock has already declined 9.55% over the past week, according to InvestingPro data. The company's current Fair Value suggests overvaluation, with concerning financial health metrics including a weak current ratio of 0.09 [2].

Bowen Acquisition Corp is a blank check company whose business purpose is to effect a merger, capital stock exchange, asset acquisition, stock purchase, reorganization, or similar business combination with one or more businesses. The company is subject to regular monitoring by Nasdaq to ensure compliance with listing standards and disclosure requirements.

References:
[1] https://finance.yahoo.com/news/bowen-acquisition-corp-receives-nasdaq-203000088.html
[2] https://www.investing.com/news/company-news/bowen-acquisition-corp-faces-nasdaq-delisting-over-compliance-93CH-4142552